Health ❯ Clinical Trials

Phase 3 Trials

Drug Efficacy Efficacy Studies Patient Studies Vaccine Efficacy ELAINE-3 Trial ACHIEVE-1 Trial Vaccine Efficacy Trials Drug Testing ACHIEVE-1 Trials EAGLE-1 Trial Patient Participation Pelabresib Trial Tuberculosis Vaccine Trials Rybelsus ATTAIN-1 Trial OASIS 4 Participant Demographics SOUL Trial Weight Loss Efficacy Eosinophilic Asthma Psilocybin Trials AFFINE Trial Weight Loss Maintenance Metabolic Dysfunction Interim Analysis GanLum Trial

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

A European Commission decision now determines EU authorization, after which Member States will set pricing and rollout.

FDA Grants Priority Review to Vera's Atacicept for IgA Nephropathy

Athira Pharma Secures Exclusive Lasofoxifene Rights, Raises $90 Million to Advance Phase 3 Breast Cancer Program

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

CSL Secures VarmX Acquisition Option, Funding Phase 3 of Factor Xa Reversal Drug

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

FDA Approves First New Fibromyalgia Treatment in 15 Years

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women